SCN9A and Kallmann syndrome: Human studies have shown that homozygous or compound heterozygous loss-of-function mutations in SCN9A, the gene which encodes Nav1.7, cause congenital insensitivity to pain (CIP) [15-17], which is accompanied by anosmia [17-19].